Scientific Advisory Board


MetrioPharm collaborates with a number of scientific key opinion leaders (KOLs) in various indications.


Senior Advisor MatrioPharm

Prof Dirk Fischer
Head Physician Neuro- and Developmental Pediatrics, University Children's Hospital Basel

Dirk Fischer, MD, PhD, Head of Neuromuscular Research, Head Physician of Neuro- and Developmental Pediatrics and Head of Electrophysiology at University Children's Hospital Basel (since 2008), Head Physician of Department of Internal Medicine at Kantonsspital Bruderholz (since 2011), and Head Physician at Department of Neurology of University Hospital Basel (since 2007). His international studies included stays in Madrid, Dublin, Buenos Aires, and London, as well as a postdoctoral fellowship at the Centre National de la Recherche Scientifique (CNRS) in Paris (2003-2005) focusing on hereditary muscular and peripheral neurological diseases such as Duchenne muscular dystrophy.


Senior Advisor MatrioPharm

Prof Ferdinando Nicoletti
Full Professor of General Pathology and Immunology, University of Catania

Ferdinando Nicoletti, MD, PhD, Full Professor of General Pathology and Immunology (since 2011) at the University of Catania (Italy). Graduated at the University of Catania in 1987 in Medicine and Surgery and specialized in Allergology and Clinical Immunology at the University of Milan (Italy) in 1990. Ferdinando Nicoletti has been external consultant at the Institute for Inflammation Research, Righsospitalet University Hospital, Copenhagen, Denmark, from 1999 until 2010; Visiting Professor at the School of Medicine of the University of Belgrade, Serbia, in 2004; Honorary Professor at Tblisi State Medical University (Georgia) in 2023. 


Senior Advisor MetrioPharm

Prof Laurent Servais
Professor of Paediatric Neuromuscular Disease, University of Oxford

Laurent Servais, MD, PhD, Professor of Paediatric Neuromuscular Disease at the University of Oxford and invited professor at the University of Liège, specialized in spinal muscular atrophy, Duchenne Muscular Dystrophy, and Myotubular Myopathy. Educated in Medicine, Paediatrics, Child Neurology, and Myology in France and Belgium, he leads two newborn screening programs in UK (SMA) and Belgium (Genomic Newborn screening). His research focuses on innovative outcome measures using wearable devices and newborn screening. He sees patients in UK and in Belgium, and leads annual consultations in Egyptian and Romanian hospitals.


Senior Advisor MatrioPharm

Prof Marcus Thelen
Emeritus, Institute for Research in Biomedicine Bellinzona

Marcus Thelen, PhD, is Honorary Professor at the University of Bern. In 2000, he co-founded the Institute for Research in Biomedicine (IRB) in Bellinzona and headed the Signal Transduction Laboratory until his retirement in 2022. In 1989, he joined the group of Alan Aderem in the Laboratory of Cellular Physiology and Immunology of the Cohn/Steinman Department at Rockefeller University, focusing on cytokine-mediated phagocyte priming and signal transduction. Following a Swiss National Science Foundation award, Marcus led a research group on leukocyte signal transduction in Bern. Marcus received his PhD from the University of Bern, specializing in inflammation and chemokines at the Theodor Kocher Institute.